Analyst firms · H.C. Wainwright · MIRM
H.C. Wainwright MIRM price target and rating history
Mirum Pharmaceuticals Inc. (MIRM) · Health Care
H.C. Wainwright rates Mirum Pharmaceuticals Inc. (MIRM) Buy with a $73 price target, as of its latest action on May 19, 2025. It has published 4 rating actions on MIRM since September 2021, including 0 upgrades and 0 downgrades. Across 3 firms with a MIRM price target in the last 12 months, the median target is $145.
- Current rating
- Buy
- Price target
- $73
- Median target, all firms
- $145
- Actions on MIRM
- 4
H.C. Wainwright price target on MIRM
Every H.C. Wainwright rating on MIRM
- May 19, 2025
- Dec 18, 2023
- Sep 30, 2021
- Sep 14, 2021
How other firms rate MIRM
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| Citigroup | Buy | $145 | Jun 2, 2026 |
| Wolfe Research | Outperform | $145 | May 19, 2026 |
| RBC Capital Markets | Outperform | $130 | Feb 18, 2026 |
Questions about H.C. Wainwright and MIRM
- What is H.C. Wainwright's price target for MIRM?
- H.C. Wainwright's latest stated price target for Mirum Pharmaceuticals Inc. (MIRM) is $73, from its action on May 19, 2025.
- What is H.C. Wainwright's rating on MIRM?
- H.C. Wainwright rates MIRM Buy, a bullish rating, as of May 19, 2025.
- When did H.C. Wainwright last change its view on MIRM?
- On May 19, 2025, H.C. Wainwright resumes coverage at Buy, price target $73.
- How does H.C. Wainwright's MIRM target compare with other analysts?
- Across 3 firms with a MIRM price target in the last 12 months, the median target is $145.
More MIRM rating histories
All H.C. Wainwright ratingsMIRM news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.